UP-02.080 Prognostic Value of Chromogranin A in Prostate Biopsy at the Moment of Diagnosis of Patients with Hormone-Refractory Prostate Cancer

J Casado Varela,I Galante Romo,L San Jose Manso,A Hernando Arteche,M Leon Rueda,E Useros Rodriguez, J Sanz Ortega, J M Puente,A Silmi Moyano,C Olivier Gomez

Urology（2011）

Cited 0|Views9

No score

Abstract

Hormonal therapy is the treatment of choice for advanced prostate cancer. Neuroendocrine differentiation of tumor has been shown to be one of the mechanisms involved in deleterious evolution of the disease, being the Chromogranin A (Cr A), an immunohistochemical marker of this differentiation to castration refractory prostate cancer. The objective is to relate the presence of chromogranin A in the biopsy specimen with the disease survival and progression and the response to chemotherapy.

Translated text

Key words

chromogranin a

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined